SAHPRA Medical Device Registration South Africa Consulting
Navigate South Africa's evolving regulatory landscape with confidence. NexorTest Technologies provides end-to-end SAHPRA medical device registration consulting, from establishment registration and device classification through listing, licensing, and post-market surveillance. As Africa's most advanced regulatory market, South Africa offers a strategic gateway for MedTech companies targeting the continent.
Africa's Gateway Market
South Africa is the continent’s most regulated and advanced MedTech market. Establishing SAHPRA registration first gives you strategic first mover advantage across Sub-Saharan Africa.
GHTF/IMDRF Aligned Framework
SAHPRA’s classification system follows internationally harmonized GHTF and IMDRF guidelines, allowing streamlined adaptation of existing CE or FDA documentation.
Our South Africa MedTech Services
NexorTest delivers comprehensive SAHPRA regulatory consulting services designed to accelerate your market entry into South Africa. From initial classification through ongoing compliance, our team manages every stage of the regulatory journey.
SAHPRA Device Registration
Complete management of the SAHPRA medical device registration process, covering both the listing pathway for Class A and B devices and the licensing pathway for Class C and D devices. We prepare your full technical dossier including device description, intended purpose, labelling review, safety and performance data, and conformity assessment evidence. Our team ensures every submission aligns with SAHPRA’s current requirements under the Medicines and Related Substances Act 101 of 1965 and the 2016 Regulations published in Government Gazette 40480. We also monitor the call-up system deadlines and prepare priority submissions for devices subject to phased registration timelines.
Establishment Registration
SAHPRA mandates that all manufacturers, importers, and distributors of medical devices operating within South Africa hold a valid establishment registration. NexorTest handles the entire establishment registration process, including preparation of your application, compilation of quality management documentation, and liaison with SAHPRA throughout the review period. Establishment registration typically takes one to three months and is a mandatory prerequisite before any device listing or licensing application can be submitted. We ensure your facility credentials are maintained and renewed on schedule.
Clinical Evidence Support
SAHPRA’s licensing pathway for higher-risk devices requires robust clinical evidence demonstrating device safety and performance. NexorTest assists with clinical evaluation report preparation, literature reviews, equivalence analyses, and clinical investigation planning where primary data generation is required. We help you build a clinical evidence portfolio that satisfies SAHPRA reviewers while leveraging existing data from CE marking or FDA submissions. Our approach minimizes the need for duplicative studies and accelerates the path to market approval.
IVD Classification & Registration
In vitro diagnostic (IVD) medical devices are subject to specific classification and registration requirements under SAHPRA’s evolving regulatory framework. NexorTest guides IVD manufacturers through the classification process aligned with IMDRF risk-based principles, preparation of performance evaluation data, and submission of IVD-specific technical documentation. As SAHPRA continues to align its IVD regulations with international standards, our consultants stay ahead of regulatory changes to keep your submissions current and compliant.
Quality Management Systems
A certified quality management system is the foundation of SAHPRA compliance. NexorTest provides end-to-end QMS consulting, including gap analysis against ISO 13485 requirements, documentation development, internal audit programs, and preparation for third-party certification audits. We also support ISO 14971 risk management integration and design control procedures tailored to South African regulatory expectations. Our QMS services ensure your organization maintains audit-ready compliance that satisfies both SAHPRA and international regulatory bodies simultaneously.
Post-Market Surveillance & Vigilance
SAHPRA requires registered device holders to maintain active post-market surveillance and report adverse events through its vigilance reporting system. NexorTest develops and implements your post-market surveillance plan, periodic safety update reports, trend analysis protocols, and adverse event reporting procedures. We establish complaint handling workflows that meet SAHPRA’s vigilance requirements while integrating with your global post-market systems. Our proactive monitoring approach helps you identify safety signals early and maintain continuous compliance with South African post-market obligations.
South Africa Medical Device Classification
SAHPRA classifies medical devices using a risk-based system aligned with GHTF and IMDRF guidelines. Classification determines the regulatory pathway, documentation requirements, and expected review timelines for your device.
| Class | Risk Level | Pathway | Device Examples | Typical Timeline |
|---|---|---|---|---|
| Class A | Low Risk | Listing | Non-sterile bandages, tongue depressors, reusable surgical instruments, examination gloves, hospital beds | 3 - 6 months |
| Class B | Low-Moderate Risk | Listing | Hypodermic needles, powered wheelchairs, ultrasound diagnostic equipment, dental filling materials, hearing aids | 3 - 6 months |
| Class C | Moderate-High Risk | Licensing | Haemodialysis equipment, ventilators, bone fixation plates, infusion pumps, orthopaedic implants | 6 - 18 months |
| Class D | High Risk | Licensing | Cardiovascular stents, pacemakers, total joint replacements, spinal implants, heart valves | 6 - 18 months |
SAHPRA’s classification rules are defined under the Medicines and Related Substances Act 101 of 1965 and the 2016 Medical Devices Regulations (Government Gazette 40480). Classification is aligned with the GHTF/IMDRF four-class risk-based system. NexorTest performs detailed classification assessments for every device to ensure the correct regulatory pathway is followed from the outset.
SAHPRA Registration Process
Our proven six-step methodology takes your medical device from initial assessment through successful SAHPRA registration. NexorTest manages every phase to minimize delays and maximize your probability of first-time approval.
Regulatory Assessment & Device Classification
We begin with a thorough regulatory assessment of your medical device, its intended purpose, and its technological characteristics. Using SAHPRA’s GHTF-aligned classification rules, we determine whether your device falls into Class A, B, C, or D and identify the appropriate pathway, either listing or licensing. This initial assessment also reviews your existing regulatory approvals from other markets such as CE marking or FDA clearance to identify documentation that can be leveraged for the South African submission.
Establishment Registration
Before any device application can be submitted, SAHPRA requires a valid establishment registration for manufacturers, importers, and distributors. NexorTest prepares your establishment registration application, compiles the required quality management documentation, and manages communications with SAHPRA until registration is granted. This step typically takes one to three months and establishes your organization’s legal standing to conduct medical device activities in South Africa.
Technical Dossier Preparation
Our regulatory affairs team compiles your complete technical dossier following SAHPRA’s documentation requirements. This includes the device description, design specifications, materials characterization, biocompatibility data, sterilization validation where applicable, labelling and instructions for use, ISO 14971 risk management file, and clinical evaluation documentation. For Class C and D devices, we prepare comprehensive clinical evidence packages including literature reviews and equivalence analyses. A Free Sale Certificate from your home market is also obtained and included.
Application Submission & SAHPRA Review
We submit your completed application through SAHPRA’s electronic portal along with all required fees and supporting documentation. For Class A and B devices, the listing submission undergoes a conformity verification review. For Class C and D devices, the licensing application receives a full technical assessment by SAHPRA’s expert reviewers. NexorTest manages all correspondence with SAHPRA during the review period, responding to queries and providing additional information as requested to maintain review momentum.
Registration Approval & Market Authorization
Upon successful review, SAHPRA issues a listing confirmation for Class A and B devices or a device licence for Class C and D devices. NexorTest verifies all registration details, ensures your device is correctly listed in SAHPRA’s database, and provides you with complete documentation of your market authorization status. We advise on labelling requirements specific to South Africa and confirm that your device packaging meets all local regulatory specifications before commercial distribution begins.
Post-Market Compliance & Ongoing Support
Regulatory compliance does not end at registration. NexorTest provides ongoing post-market surveillance support, including adverse event and vigilance reporting to SAHPRA, periodic safety update report preparation, and registration renewal management. We monitor SAHPRA regulatory updates, call-up notices for additional device categories, and guideline changes that may affect your registered products. Our ongoing support ensures your devices remain compliant throughout their commercial lifecycle in South Africa.
Why Choose NexorTest for South Africa
NexorTest brings unmatched expertise and a first mover advantage in the African MedTech regulatory space. Our dedicated South Africa consulting team combines deep SAHPRA knowledge with global regulatory experience.
First Mover Advantage in Africa
South Africa is Africa's most advanced regulatory market, and NexorTest is one of the first global consulting firms to establish dedicated SAHPRA expertise. Gaining registration in South Africa positions your products for faster market entry across Sub-Saharan Africa through AMRH harmonization initiatives. Our early presence in this market gives our clients a significant competitive edge over companies that have yet to build African regulatory capabilities.
Deep SAHPRA Regulatory Knowledge
Our consultants maintain current expertise on SAHPRA's evolving regulatory framework, including the transition from the old MCC system, the call-up registration schedule, and emerging guidelines for software as a medical device and UDI implementation. We understand the practical realities of SAHPRA's review processes and prepare submissions that anticipate common reviewer queries and avoid processing delays.
98% First-Time Approval Rate
Our meticulous approach to dossier preparation and quality review delivers a 98% first-time approval rate across all SAHPRA submissions. Every application undergoes internal peer review by senior regulatory professionals before submission, ensuring completeness and compliance with current SAHPRA expectations. This rigorous quality standard minimizes costly resubmissions and keeps your market entry timeline on track.
ISO 13485 & ISO 14971 Expertise
SAHPRA requires evidence of ISO 13485 certified quality management systems and ISO 14971 compliant risk management processes. NexorTest's quality systems team provides gap analysis, documentation development, and audit preparation services that ensure your QMS meets both South African and international requirements. Our integrated approach means your quality systems support regulatory submissions across multiple markets simultaneously.
Accelerated Market Entry Timelines
We leverage existing CE marking, FDA clearance, and other international approvals to prepare SAHPRA submissions efficiently. By adapting your existing documentation rather than creating it from scratch, we reduce preparation time by up to forty percent compared to starting fresh. Our established relationships with the SAHPRA review process ensure smooth communications and faster resolution of any queries that arise during assessment.
Pan-African Regulatory Strategy
As a founding member of the African Medicines Regulatory Harmonisation initiative, South Africa's regulatory framework influences MedTech regulation across the continent. NexorTest helps you use your SAHPRA registration as a springboard for broader African market access, advising on AMRH recognition pathways and supporting parallel submissions in other African markets where your South African approval provides a regulatory advantage.
Frequently Asked Questions
Get clear answers to common questions about SAHPRA medical device registration, South Africa regulatory requirements, and how NexorTest can support your market entry strategy.
How do I register a medical device in South Africa with SAHPRA?
To register a medical device in South Africa, you must submit an application to the South African Health Products Regulatory Authority (SAHPRA). Class A and B devices follow the listing pathway, requiring conformity assessment and technical documentation. Class C and D devices require full licensing, involving detailed clinical evidence, risk management files, and quality system documentation. All manufacturers, importers, and distributors must hold a valid SAHPRA establishment registration before any device application can be submitted.
What is the SAHPRA medical device call-up system?
The SAHPRA call-up system is a phased registration process for medical devices that were previously on the South African market without formal registration under the old Medicines Control Council (MCC) system. SAHPRA issues call-up notices by device category, setting deadlines by which manufacturers must submit registration applications. Devices that fail to meet call-up deadlines risk being withdrawn from the market. NexorTest monitors all call-up notices and ensures your submissions are prepared and filed before each deadline.
What is the difference between SAHPRA device listing and licensing?
SAHPRA device listing applies to Class A (low risk) and Class B (low-to-moderate risk) devices and is a streamlined notification process with shorter review timelines of three to six months. Licensing applies to Class C (moderate-to-high risk) and Class D (high risk) devices and involves a comprehensive review of clinical data, risk management, and quality management systems, typically taking six to eighteen months. Both pathways require valid establishment registration and compliance with ISO 13485.
Do I need an establishment registration to sell medical devices in South Africa?
Yes, SAHPRA requires all manufacturers, importers, and distributors of medical devices operating in South Africa to hold a valid establishment registration. This registration confirms that your organization meets minimum quality and operational standards. The establishment registration process typically takes one to three months and must be completed before you can submit any device listing or licensing application.
How long does SAHPRA medical device registration take?
SAHPRA registration timelines vary by device classification. Class A and Class B devices processed through the listing pathway typically take three to six months. Class C and Class D devices that require full licensing generally take six to eighteen months due to the detailed review of clinical evidence and risk management documentation. Establishment registration usually takes one to three months. NexorTest helps streamline these timelines by preparing submission-ready dossiers that minimize queries and review delays.
Does SAHPRA accept CE marking or FDA clearance as supporting evidence?
SAHPRA does not automatically recognize CE marking or FDA 510(k) clearance as a substitute for its own registration process. However, holding CE or FDA approval serves as strong supporting evidence of device safety and performance. SAHPRA’s classification system is aligned with the GHTF and IMDRF frameworks, so documentation prepared for EU MDR or FDA submissions can often be adapted for South African requirements with targeted modifications. A Free Sale Certificate from your home market is also typically required.
Start Your South Africa Market Entry Today
Partner with NexorTest to navigate SAHPRA’s regulatory requirements and gain first mover advantage in Africa’s most advanced MedTech market. Our expert consultants are ready to guide your medical device registration from classification through commercial launch.